Detalhe da pesquisa
1.
Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer.
Int J Cancer
; 145(4): 1083-1089, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30761532
2.
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.
Lancet
; 385(9980): 1843-52, 2015 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862517
3.
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients.
BMC Cancer
; 16: 123, 2016 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26892682
4.
A cost-consequence model of using the 21-gene assay to identify patients with early-stage node-positive breast cancer who benefit from adjuvant chemotherapy in the Netherlands.
J Med Econ
; 27(1): 445-454, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38436289
5.
Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands.
Int J Breast Cancer
; 2022: 5909724, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36250028
6.
Loss of skeletal muscle index and survival in patients with metastatic colorectal cancer: Secondary analysis of the phase 3 CAIRO3 trial.
Cancer Med
; 9(3): 1033-1043, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31850687
7.
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA.
J Mol Diagn
; 21(1): 123-137, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30296589
8.
Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients.
Mol Oncol
; 12(1): 48-57, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29063679
9.
Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor.
Neoplasia
; 18(11): 647-653, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27764697
10.
Neutrophil-guided dosing of anthracycline-cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study.
Med Oncol
; 32(4): 113, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25772511
11.
Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer.
Cancer Lett
; 362(1): 36-44, 2015 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25797316
12.
Population pharmacokinetics of cisplatin in adult cancer patients.
Cancer Chemother Pharmacol
; 54(2): 105-12, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15127229
13.
Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.
Eur J Cancer
; 47(15): 2273-81, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21741829
14.
Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment.
J Clin Oncol
; 29(24): 3240-6, 2011 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21768449
15.
mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
Clin Cancer Res
; 17(11): 3600-18, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21505063
16.
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: a randomised phase II trial.
Eur J Cancer
; 46(18): 3200-4, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20727735
17.
[Lower costs for anticancer drugs by safety margin around calculated dose and by fine-tuning on ampoule strength]. / Minder kosten voor antikankermiddelen door veiligheidsmarge rond de berekende dosis en door afstemming op ampulsterktes.
Ned Tijdschr Geneeskd
; 153: B162, 2009.
Artigo
em Holandês
| MEDLINE | ID: mdl-19785801
18.
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.
J Clin Oncol
; 27(12): 1999-2006, 2009 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289619
19.
Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values.
J Clin Oncol
; 24(10): 1499-506, 2006 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16574999